Demis Hassabis, CEO of Google DeepMind, offered details about the future of Gemini AI, AGIs, and self-aware systems.

Hassabis pointed out the potential of AI to transform medicine by significantly lessening the time and expense of drug development.

Researchers from Stanford University and Google DeepMind have unveiled Step-Wise Reinforcement Learning (SWiRL), a technique ...

Artificial general intelligence could be here within the coming years,” writes Shane Legg, Co-Founder and Chief AGI Scientist ...

Google Gemini is a powerful artificial intelligence that can simplify day-to-day tasks. Here's what you need to know.

OpenAI has announced support for Anthropic's Model Context Protocol (MCP), joining Microsoft, AWS, and Google in adopting the ...

Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug ...

Digital Guider analyzes DeepMind’s AGI roadmap and its impact on SEO, AI-driven tools, and ethical marketing practices.

Arvore Partners LP (“Arvore”) is pleased to announce that it has declared its March monthly distribution at an annualized rate of 10.25% for Series W and Series F1. The distribution will be paid to ...

Minutes interviewed Google DeepMind CEO Demis Hassabis on “what’s next for AI,” with a hint about where Gemini is going.

Chatbots' popularity has been tempered from the start by the prospect of prompt injection attacks. Google DeepMind's CaMeL ...

Google DeepMind CEO Demis Hassabis showed 60 Minutes Genie 2, an AI model that generates 3D interactive environments, which ...